WS #13346
Vertex raises FY2026 sales guidance and beats Q2 estimates, signaling strength in biotech.
Vertex Pharmaceuticals earnings beat
Vertex raises FY2026 sales guidance and beats Q2 estimates, signaling strength in biotech.
Vertex raises FY2026 sales guidance and beats Q2 estimates, signaling strength in biotech.
Vertex raises FY2026 sales guidance and beats Q2 estimates, signaling strength in biotech.